Unlike PCSK9, there was no association between the genetically proxied HMG-CoA reductase nor the cholesterol transporter NPC1L1 with reduced PC risk, suggesting the important oncogenic role of PCSK9 in PC [55]. Here, PCSK9 is linked to pachyonychia congenita.